-
-
-
-
-
-
-
BioNTech SE (BNTX) Misses Q3 EPS by 22c; lifts guidance
-
-
-
-
-
-
-
BioNTech SE (BNTX) Reports Q4 EPS of EUR1.08; offers guidance
-
-
-
-
-
-
-
Midday movers: Apple, Nvidia, Intel, Coinbase and Moderna fall
-
-
-
-
-
-
-
BioNTech (BNTX) PT Lowered to $122 at BMO Capital
-
-
-
-
-
-
-
After earnings plunge, BioNTech pins hopes on cancer drug launches
-
-
-
-
-
-
-
BIONTECH INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In BioNTech To Contact Him Di
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Mercury Systems, Onsemi, BioNTech, and BioVie and Encourages Investors to Contact the Firm
-
1,198,946 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

